IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MMED

Balance Sheet

(in billions USD)
MetricQ1 2027Q3 2026Q2 2026Q2 2025Q2 2024Q2 2023
Cash & Equivalents0.210.010.300.010.050.06
Accounts Receivable0.180.650.200.57----
Inventory0.360.410.340.31----
Total Current Assets1.421.111.350.94----
Property, Plant & Equipment0.740.700.710.71----
Goodwill2.262.262.262.26----
Intangible Assets0.100.110.110.13----
Total Non-current Assets*3.303.243.283.26----
Total Assets4.724.344.634.20----
Accounts Payable0.250.300.160.21----
Total Current Liabilities0.780.700.700.71----
Total Non-current Liabilities*0.320.190.320.16----
Total Liabilities1.100.881.020.87----
Retained Earnings(0.12)--(0.12)0.00----
Total Stockholder Equity3.623.463.613.333.453.40
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ1 2027Q4 2026Q3 2026Q3 2025
Total Revenue843.00837.00843.00723.00
Cost of Revenue378.00357.00378.00314.00
Gross Profit465.00480.00465.00409.00
Selling, General & Admin312.00299.00312.00283.00
Total Operating Expenses460.00573.00460.00422.00
Operating Income5.00(93.00)5.00(13.00)
Pretax Income4.00(92.00)4.00(13.00)
Tax Provision4.0093.004.003.00
Net Income0.00(185.00)0.00(19.00)
Basic EPS0.00(0.71)0.00(0.08)
Diluted EPS0.00(0.71)0.00(0.08)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ1 2027Q4 2026Q3 2026Q3 2025
Operating Cash Flow(49.00)(170.00)(49.00)(141.00)
Capital Expenditures41.0056.0041.0053.00
Free Cash Flow*(90.00)(226.00)(90.00)(194.00)
Investing Cash Flow(41.00)(56.00)(41.00)(63.00)
Financing Cash Flow0.00512.000.00202.00
← Scroll for more columns →

* Derived from reported values